Salk researchers show how two experimental Alzheimer’s drugs protect the brains of mice from other aspects of aging
In mouse models of Alzheimer’s disease, the investigational drug candidates known as CMS121 and J147 improve memory and slow the degeneration of brain cells. Now, Salk researchers have shown how these compounds can also slow aging in healthy older mice, blocking the damage to brain cells that normally occurs during aging and restoring the levels of specific molecules to those seen in younger brains.
The research, published last month in the journal eLife, suggests that the drug candidates may be useful for treating a broader array of conditions and points out a new pathway that links normal aging to Alzheimer’s disease.
“This study further validated these two compounds not only as Alzheimer’s drug candidates but also as potentially more widely useful for their anti-aging effects,” says Pamela Maher, a senior staff scientist at Salk and a co-corresponding author of the new paper.
Old age is the biggest risk factor for Alzheimer’s disease—above the age of 65, a person’s risk of developing the disease doubles about every five years. However, at a molecular level, scientists aren’t sure what occurs in the brain with aging that contributes to Alzheimer’s.
“The contribution of old age-associated detrimental processes to the disease has been largely neglected in Alzheimer’s disease drug discovery,” says Antonio Currais, a Salk staff scientist and first author of the new paper.
Maher and David Schubert, the head of Salk’s Cellular Neurobiology Lab, previously developed CMS121 and J147, variants of plant compounds with medicinal properties. Both compounds tested positive for their ability to keep neurons alive when exposed to cellular forms of stress related to aging and Alzheimer’s disease. Since then, the researchers have used the drug candidates to treat Alzheimer’s in animal models of the disease. But experiments revealing exactly how the compounds work suggested that they were targeting molecular pathways also known to be important in longevity and aging.
In the new research, Maher, Currais and their colleagues turned to a strain of mice that ages unusually fast. A subset of these mice was given CMS121 or J147 beginning at nine months old—the equivalent of late middle age in humans. After four months, the team tested the memory and behavior of the animals and analyzed genetic and molecular markers in their brains.
Not only did the animals given either of the drug candidates perform better on memory tests than mice that hadn’t received any treatment, but their brains showed differences at the cellular and molecular levels. In particular, expression of genes associated with the cell’s energy-generating structures called mitochondria was preserved by CMS121 and J147 with aging.
“The bottom line was that these two compounds prevent molecular changes that are associated with aging,” says Maher.
More detailed experiments showed that both drugs affected mitochondria by increasing levels of the chemical acetyl-coenzyme A (acetyl-coA). In isolated brain cells, when the researchers blocked an enzyme that normally breaks down acetyl-CoA, or when they added extra amounts of an acetyl-coA precursor, they saw the same beneficial effect on mitochondria and energy generation. The brain cells became protected against the normal molecular changes associated with aging.
“There was already some data from human studies that the function of mitochondria is negatively impacted in aging and that it’s worse in the context of Alzheimer’s,” says Maher. “This helps solidify that link.”
Maher and Currais are planning future experiments to test the effects of CMS121 and J147 on how other organs age. They also hope to use the new results to inform the development of new Alzheimer’s drugs; targeting other molecules in the acetyl-coA pathway may help treat the disease, they hypothesize.
“We are now using a variety of animal models to investigate how this neuroprotective pathway regulates specific molecular aspects of mitochondrial biology, and their effects on aging and Alzheimer’s,” says Currais.
Learn more: Alzheimer’s drug candidates reverse broader aging, study shows
Go deeper with Bing News on:
Ageing
- Ageing with a purpose
KOCHI: Run the race in your prime years. Count the trophies in your twilight. Today we run multiple marathons while young, goaded by the aspirations thrown at us at regular intervals. Finally, as we ...
- 'More full-day closures likely for ageing MTR'
An MTR engineer-turned-lawmaker said on Thursday that a full-day closure of the Kwun Tong line for maintenance is essential, adding that more short-term closures are likely to be required as the ...
- How to fix fire safety in Hong Kong’s ageing buildings
The latest wake-up call was a deadly fire in a 60-year-old building that had failed to comply with fire safety orders for years. One way to solve the problem is for the authorities to directly engage ...
- In rapidly ageing China, millions just cannot afford retirement
HONG KONG: After three decades of selling homemade buns on the streets of the Chinese city of Xian, 67-year-old Hu Dexi would have liked to slow down. Instead, Hu and his older wife have moved to the ...
- Ageing business owners and rising insolvencies ‘creating perfect storm’
RSM Australia has urged the government to address issues threatening the sustainability of Australia’s small business sector in the upcoming budget.
Go deeper with Google Headlines on:
Ageing
[google_news title=”” keyword=”ageing” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Aging
- Final report envisions moving aging jail out of downtown Jacksonville, creating $1B, campus-style facility
A city committee has filed its final report on what needs to happen to move the county jail out of downtown and build a new, $1 billion campus-style facility somewhere in Duval County.
- When Does It Become Unsafe For Your Aging Parent To Live Alone?
Here I’ll address just two of these six, as very common areas of risk for aging loved ones. Elders often resist the idea of any assistive devices to help them walk safety. A cane, a walker or ...
- Main Line School Night discusses Aging Smarter
Main Line School Night (MLSN) our largest provider of non-accredited adult education classes in Philadelphia’s Main Line and surrounding communities hosted a discussion on ...
- Hundreds learn about aging well at Local 12's annual Health and Retirement Expo
SHARONVILLE, OH (WKRC) - Hundreds turned out Wednesday at Local 12's Health and Retirement Expo at the Sharonville Convention Center. Those who attended learned steps to stay well as they age. Step 1: ...
- $900M Caltrans Project Set to Replace Aging Stockton Channel Bridges
The project will replace the existing bridges built in the 1970s which have suffered significant deterioration over the years.
Go deeper with Google Headlines on:
Aging
[google_news title=”” keyword=”aging” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]